+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Herceptin"

Metastatic Breast Cancer Treatment Market Report 2025 - Product Thumbnail Image

Metastatic Breast Cancer Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Trastuzumab Biosimilars Market Report 2025 - Product Thumbnail Image

Trastuzumab Biosimilars Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
Breast Cancer Pipeline Analysis Report - Product Thumbnail Image

Breast Cancer Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
Breast Cancer Diagnostic and Drug Technologies: Global Markets - Product Thumbnail Image

Breast Cancer Diagnostic and Drug Technologies: Global Markets

  • Report
  • November 2019
  • 150 Pages
  • Global
From
From
UAE Breast Cancer Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Thumbnail Image

UAE Breast Cancer Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • January 2025
  • 82 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
From
Bevacizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Bevacizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
Trastuzumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Trastuzumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
From
From
  • 19 Results (Page 1 of 1)
Loading Indicator

Herceptin is a monoclonal antibody used to treat certain types of breast and gastric cancer. It is also used in the treatment of non-small cell lung cancer (NSCLC). Herceptin works by targeting the HER2 protein, which is found in higher levels in some types of cancer cells. This helps to slow down or stop the growth of cancer cells. Herceptin is used in combination with chemotherapy and other drugs to treat NSCLC. Herceptin is a relatively new drug in the lung cancer market, but it has been shown to be effective in treating certain types of NSCLC. It is generally well-tolerated and has fewer side effects than other treatments. Herceptin is also used in combination with other drugs to treat metastatic NSCLC, which is when the cancer has spread to other parts of the body. Herceptin is available in both generic and brand-name versions. It is typically administered intravenously in a hospital or clinic setting. Some companies in the Herceptin market include Genentech, Roche, Merck, and Pfizer. Show Less Read more